Tsubota Laboratory Inc. (4890) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tsubota Laboratory Inc. (4890:JPX), powered by AI.

Current Price
¥223
P/E Ratio
27.7
Market Cap
5.7B
Sector
Healthcare
What is the Tsubota Laboratory Inc. stock price forecast?

Tsubota Laboratory Inc. is currently trading at ¥223. View real-time AI analysis on Alpha Lenz.

What is Tsubota Laboratory Inc. insider trading activity?

View the latest insider trading data for Tsubota Laboratory Inc. on Alpha Lenz.

What is Tsubota Laboratory Inc.'s P/E ratio?

Tsubota Laboratory Inc.'s P/E ratio is 27.7.

Tsubota Laboratory Inc.

JPX · 4890
¥223+4(+1.83%)Market closedJPX regular session 09:00–15:00 JST
Ask about Tsubota Laboratory Inc.'s future dividend policy...
Alpha Chat Insight

Tsubota Laboratory Inc. trades at a P/E of 27.7 (premium valuation) with solid ROE of 13.9%. 3Y revenue CAGR of 28.4% highlights clear growth momentum.

Ask for details

Company Overview

Tsubota Laboratory Inc. is a company specializing in the development and commercialization of innovative health and wellness products. It focuses primarily on advancing new technologies and methodologies to support vision health, among other medical and lifestyle areas. The firm leverages cutting-edge research to create solutions that cater to various demographics concerned with eye care and general well-being. By integrating scientific research with practical product development, Tsubota Laboratory significantly impacts the healthcare and wellness sector. It often collaborates with academic institutions and other industry players to enhance its product offerings. Based in Japan, Tsubota Laboratory plays a crucial role in the expanding intersection of healthcare technology and consumer wellness products, reflecting the growing market demand for preventative care solutions worldwide.

CEOMr. Kazuo Tsubota M.B.A., M.D., Ph.D.
SectorHealthcare
IndustryMedical Devices
Employees17

Company Statistics

FY 2025

Profile

¥5,707,191,278Market Cap
¥1,357,133,000Revenue
0.00Shares Out
17Employees

Margins

86.72%Gross
22.82%EBITDA
17.35%Operating
20.71%Pre-Tax
15.16%Net

Valuation

27.74P/E
3.60P/B
4.21EV/Sales
13.75EV/EBITDA
-16.96P/FCF

Growth (CAGR)

28.41%Rev 3Yr
25.17%Rev 5Yr
20.03%Op Inc 3Yr
74.22%Op Inc 5Yr
10.30%Net Inc 3Yr
132.70%Net Inc 5Yr

Returns

8.58%ROA
13.93%ROE
11.76%ROIC

Financial Health

¥1,538,853,000Cash & Cash Equivalents
¥-623,003,000Net Debt
57.70%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tsubota Laboratory Inc. (ticker: 4890) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 17 employees. Market cap is $5.7B.

The current price is 223 with a P/E ratio of 27.74x and P/B of 3.6x.

ROE is 13.93% and operating margin is 17.35%. Annual revenue is $1.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tsubota Laboratory Inc. (4890) Stock Forecast 2026 ¥223 — Price, Financials & Analyst Targets | Alpha Lenz